MOLECUBES NV, in partnership with LabLogic Systems Inc., has recently installed a β-X-CUBE imaging platform in the lab of Prof. Paul R. Territo at the Indiana University School of Medicine for their research supporting the MODEL-AD and TREAT-AD grants provided by NIH/NIA as consortium open science grants. The goal of these grants is to evaluate and characterize new animal models for Late Onset Alzheimer’s Disease (LOAD) and use these newly acquired insights to evaluate target engagement of novel and existing pharmaceuticals. As such, this work will advance the understanding of LOAD and provide the scientific community with an extended toolbox to accelerate research in this therapeutic area.

Read full article

The Translational Research Institute (TRI) in Brisbane has recently replaced its Inveon preclinical PET/CT with a B- and X-CUBE from MOLECUBES. The addition of this bench top imaging combination complements their existing state-of-the-art in vivo imaging infrastructure. The MOLECUBES PET/CT will facilitate the translational and basic research programs at TRI, ensuring they remain at the forefront of breakthrough discoveries. The key reasons TRI chose MOLECUBES are the high-end and high-throughput PET/CT capabilities, and the user-friendliness of the system. MOLECUBES is proud to have this institute as their first customer in Australia and is looking forward to further intensive collaborations to advance translational research.

Discover MOLECUBES’ uniques features that enable high throughput screening trials using molecular imaging.

In this webinar, Dr. Sara Neyt and Dr. Kim Braeckman will highlight the most relevant high throughput imaging screening features that enable a faster discovery process. The focus will be on the unique features MOLECUBES provides to accelerate your research. A few selected applications will be highlighted to demonstrate these features in the daily practice of an imaging lab/screening core.

Date and time: April 29th at 17:00 CET/11:00 AM EST

Register here